Washington University in St. Louis

Washington University Open Scholarship
Volume 13

Washington University
Undergraduate Research Digest

Spring 2018

Tracking Transcription Factors: Validating the Brd4-HypB Calling
Card System in vitro
Lucia Grandison
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/wuurd_vol13

Recommended Citation
Grandison, Lucia, "Tracking Transcription Factors: Validating the Brd4-HypB Calling Card System in vitro"
(2018). Volume 13. 71.
https://openscholarship.wustl.edu/wuurd_vol13/71

This Abstracts A-I is brought to you for free and open access by the Washington University
Undergraduate Research Digest at Washington University Open Scholarship. It has been accepted for inclusion in
Volume 13 by an authorized administrator of Washington University Open Scholarship. For more information,
please contact digital@wumail.wustl.edu.

Toward a Better Understanding of...

Tracking Transcription Factors:
Validating the Brd4-HypB Calling Card
System in vitro
Lucia Grandison
Mentors: Joe Dougherty and Darshan Sapkota
Transcription factors play critical roles in the development of nearly all cell types. While
methods currently employed to study transcription factor binding events are limited to
only tagging transcription factors bound to the DNA when transcription was halted,
a new technology known as the calling card system is able to exhaustively record the
memory of transcription factor binding events. Calling card technology harnesses the
functionality of genetic transposable elements to identify the targets of DNA binding
proteins. When a transposase is fused with a transcription factor, the transposon enzyme
will deposit its genetic cargo close to the tagged transcription factor’s binding site. Thus,
one can track transcription factor binding by looking for transposon insertions.
The purpose of this research project was to assess the functionality of the Brd4HypBase calling card construct. To create this construct, the general transcription factor
Brd4 was fused with a HyperpiggyBac (HypB) transposase and a DHFR degradation
domain (DD), all of which was put under the control of a Tet-On promoter. This
construction, in theory, would allow for the tight regulation, both transcriptionally
and post-translationally, of the Brd4-HypB construct using doxycycline (Dox) and
trimethoprim (Tmp), respectively. After culturing primary astrocytes from neonatal
mice carrying the TetOn-Brd4-HypB-DHFRDD allele, qPCR and Western blot analyses
were performed on cells treated with one of the four combinations of Dox and Tmp
to compare the amounts of Brd4-HypB mRNA and stabilized Brd4-HypB protein in
treated vs. untreated cells. The qPCR results indicated no significant difference between
the amounts of Brd4-HypB mRNA in cells treated with Dox compared to untreated
cells, indicating a possible issue with the promoter. Similarly, the Western blot results
indicated no significant difference between the amount of Brd4-HypB protein detected
in cells treated with Tmp vs. untreated cells.
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